271980 — Jeil Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual cashflow statement for Jeil Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-10,585	6,965	-14,986	-15,009	5,201
Depreciation
Amortisation
Non-Cash Items	16,373	12,765	14,760	6,980	5,897
Unusual Items
Purchased R&D
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	15,563	-47,769	10,194	-16,004	-25,846
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	28,958	-19,046	19,100	-15,147	-4,981
Capital Expenditures	-1,396	-2,867	-5,393	-16,958	-9,576
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	250	-2,710	-2,645	4,034	-2,343
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-1,146	-5,577	-8,037	-12,924	-11,919
Financing Cash Flow Items	—	38	27,498	26,001	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-16,589	15,133	11,069	33,618	18,766
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	11,020	-9,622	22,070	5,483	1,545